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SUMMARY latter include AIF, Omi/HtrA2 and Endonuclease G, although theirDuring apoptosis, mitochondrial outer membrane
permeabilization (MOMP) is often a point-of-no-re-
turn; death can proceed even if caspase activation
is disrupted. However, under certain conditions,
resistance to MOMP-dependent, caspase-indepen-
dent cell death is observed. Mitochondrial recovery
represents a key process in this survival. Live cell
imaging revealed that during apoptosis not all mito-
chondria in a cell necessarily undergo MOMP. This
incomplete MOMP (iMOMP) was observed in
response to various stimuli and in different cell types
regardless of caspase activity. Importantly, the pres-
ence of intact mitochondria correlated with cellular
recovery following MOMP, provided that caspase
activity was blocked. Such intact mitochondria
underwent MOMP in response to treatment of cells
with the Bcl-2 antagonist ABT-737, suggesting that
the resistance of these mitochondria to MOMP lies
at the point of Bax or Bak activation. Thus, iMOMP
provides a critical source of intact mitochondria
that permits cellular survival following MOMP.
INTRODUCTION
In response to most stimuli, engagement of apoptosis involves
mitochondrial outer membrane permeabilization (MOMP), which
in turn leads to widespread activation of executioner caspases.
The proteolytic activity of these caspases causes the physiological
hallmarks of apoptosis, including DNA fragmentation, nuclear
condensation, phosphatidylserine externalization, and plasma
membrane blebbing (Taylor et al., 2008). Although caspase activa-
tion is the defining characteristic of apoptosis, cells that undergo
MOMP but are prevented from activating executioner caspases
by chemical inhibitors or by genetic ablation of Apaf-1 or cas-
pase-9 will nonetheless die (Amarante-Mendes et al., 1998;
Haraguchi et al., 2000; McCarthy et al., 1997; Xiang et al., 1996).
MOMP-dependent, caspase-independent cell death (CICD) may
be due to loss of mitochondrial function caused by MOMP, and/
or by release of mitochondrial proteins that can kill a cell in a cas-
pase-independentmanner (Tait and Green,2008).Examplesof the802 Developmental Cell 18, 802–813, May 18, 2010 ª2010 Elsevier Inroles in mediating CICD remain controversial (Li et al., 2001; Susin
et al., 1999; Suzuki et al., 2001). That CICD is dependent on MOMP
is evidenced by observations that expression of antiapoptotic
Bcl-2 proteins (Haraguchi et al., 2000) or lack of the proapoptotic
Bcl-2 effectors, Bax and Bak, (Lum etal., 2005) preventscell death.
These findings have led to the view that MOMP represents
a point-of-no-return for cell death. However, this is not always
the case. For example, postmitotic sympathetic neurons
deprived of neurotrophic factor undergo MOMP but remain
viable provided caspase activity is inhibited and growth factor
is replenished (Deshmukh et al., 2000; Martinou et al., 1999).
Recently, we found that proliferating cells can also recover
following MOMP. By employing a retroviral based cDNA screen
for inhibitors of CICD, we identified glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) as being able to promote cellular
survival following MOMP and allow clonogenic outgrowth (Colell
et al., 2007). This protective effect of GAPDH was dependent
upon its well-defined glycolytic role and a novel role in stimu-
lating mitophagy, in part, through upregulation of Atg12.
The ability of cells to recover from MOMP has a variety of clin-
ical implications, including implications for oncogenesis. For
example, tumor cell lines often display reduced caspase activity
owing to a lack of Apaf-1 expression, apoptosome activity, or
caspase expression (Devarajan et al., 2002; Ferreira et al.,
2001; Soengas et al., 2001; Wolf et al., 2001). Alternatively,
some tumors overexpress inhibitor of apoptosis proteins (IAPs)
that can directly inhibit caspase function (Krajewska et al.,
2003; Tamm et al., 2000). Moreover, expression of a dominant
negative form of caspase-9 in vivo (which prevents caspase acti-
vation following MOMP) has been shown to enhance survival
and proliferation of transformed cells (Schmitt et al., 2002).
These studies suggest that tumor cells have developed means
of inhibiting caspase activity downstream of MOMP. The ability
of tumor cells to recover and proliferate after MOMP would facil-
itate tumor cell survival and chemotherapeutic resistance.
How mitochondrial repopulation occurs during cellular
recovery from MOMP is unknown. Mitochondrial function is crit-
ical for survival following MOMP because only cells that maintain
DJm are able to survive (Colell et al., 2007; Deshmukh et al.,
2000). However, in order to recover from MOMP and proliferate,
cells must either generate or already possess a source of
healthy, intact mitochondria. In this study we set out to address
how cells, following MOMP, can produce an essential pool of
intact mitochondria to enable cellular survival.c.
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Incomplete Mitochondrial Outer Membrane
Permeabilization during Apoptosis
To facilitate study of mitochondrial repopulation following
MOMP, we first sought to define a system in which intact mito-
chondria could readily be distinguished from permeabilized
mitochondria via single-cell imaging of live cells. Previous
studies have shown that, provided caspase activity is inhibited,
Smac/Diablo and Omi are degraded in a proteasome-dependent
manner following their release from mitochondria during
apoptosis (MacFarlane et al., 2002; Sun et al., 2004). We
reasoned that Smac and Omi fluorescent fusion proteins might
also be degraded following MOMP, thereby facilitating the
detection of intact mitochondria, which would remain bright.
To address this, we generated HeLa cells stably expressing
Smac-GFP or Omi-mCherry. Both Smac-GFP and Omi-mCherry
displayed appropriate mitochondrial localization and were
released from mitochondria following cell treatment with the
apoptotic stimulus actinomycin D (ActD) (data not shown).
Next, we treated HeLa cells expressing Smac-GFP or Omi-
mCherry with staurosporine (STS) in the presence of the pan-
caspase inhibitor quinolyl-valyl-O-methylaspartyl-[2,6-difluoro-
phenoxy]-methyl ketone (Q-VD-OPh) and examined them by
live-cell microscopy. HeLa cells stably expressing cytochrome
c-GFP have been previously described and were used for
comparison (Goldstein et al., 2005). The total brightness of cells
was assessed and plotted relative to the onset of MOMP
(Figure 1A). Mitochondrial release of Smac-GFP and Omi-
mCherry was rapid and occurred with similar kinetics as cyto-
chrome c, consistent with previous results (Munoz-Pinedo
et al., 2006). However, unlike cytochrome c, Smac-GFP and
Omi-mCherry were degraded following MOMP, as detected by
a gradual loss of fluorescence that initiated at the onset of
MOMP. These results demonstrate that Smac-GFP and Omi-
mCherry display appropriate mitochondrial localization, are
released with the expected kinetics following MOMP, and similar
to endogenous Smac and Omi, are degraded following MOMP.
We next employed these fluorescent tools to investigate if
a limited number of intact mitochondria persist in cells following
MOMP. HeLa cells expressing Smac-GFP were treated with
ActD in the presence of Q-VD-OPh and imaged by live-cell
microscopy (Figure 1B; see Movie S1 available online). Although
MOMP, corresponding to rapid mitochondrial release of Smac-
GFP, was readily detected in these cells, we noticed that in
many cells MOMP appeared to be incomplete such that certain
mitochondria failed to undergo permeabilization, as evidenced
by a continued punctate distribution of Smac-GFP. We define
this incomplete MOMP (iMOMP) as the persistence of a subset
of intact mitochondria within a cell that has undergone MOMP.
Incomplete MOMP was confined to a minority of mitochondria
within the cell (Figure 1B) and was also observed in response
to UV or STS treatment in the presence of Q-VD-OPh
(Figure S1A). Quantification of cells that displayed iMOMP re-
vealed that, regardless of apoptotic stimulus, approximately
25% of cells displayed iMOMP (Figure 1C). To verify that the re-
maining punctate Smac-GFP following MOMP was localized to
mitochondria we treated HeLa cells expressing Smac-GFP and
mitochondrial matrix targeted dsRed (mito dsRed) with UV andDeveQ-VD-OPh and then imaged them by live-cell microscopy
(Figure 1D). In cells that displayed iMOMP, the punctate Smac-
GFP signal co-localized with the mito dsRed signal indicating
that it was indeed localized to the mitochondria. Other mitochon-
drial intermembrane space (IMS) proteins besides Smac-GFP
were also used to visualize iMOMP. HeLa cells coexpressing
Smac-GFP and Omi-mCherry were treated with ActD plus
Q-VD-OPh and imaged by live-cell microscopy (Figure 1E).
Following treatment, in some cells, Omi-mCherry displayed
punctate distribution following MOMP that colocalized with
Smac-GFP. Furthermore, we also found that upon treatment of
HeLa cells expressing cytochrome c-GFP with ActD or UV,
puncta corresponding to mitochondrially localized cytochrome
c-GFP persisted following MOMP in some cells (Figure S1B).
These results demonstrate that iMOMP can be detected using
a variety of IMS fluorescent fusion proteins. We further investi-
gated whether iMOMP could be detected by examining endog-
enous IMS protein distribution following MOMP. HeLa cells ex-
pressing Smac-GFP were treated with UV or ActD in the
presence of Q-VD-OPh, and immunostained for endogenous
cytochrome c (Figure 1F). In untreated cells, cytochrome c and
Smac-GFP displayed complete colocalization. Following
apoptotic stimuli, continued mitochondrial colocalization of
cytochrome c and Smac-GFP in a subset of intact mitochondria
was detected in some cells undergoing MOMP, demonstrating
that iMOMP can also be detected by examination of endoge-
nous IMS proteins. In addition we examined the colocalization
of endogenous Smac and cytochrome c with mito dsRed, and
observed that in cells that had undergone MOMP following treat-
ment with STS there was persistence of puncta corresponding to
mitochondrially localized cytochrome c or Smac (Figure S1C).
Collectively, these data demonstrate that during apoptosis
MOMP can be incomplete, leaving some mitochondria intact.
Incomplete MOMP Is Cell-Type and Caspase
Independent
To extend our observations to other cell lines, MCF-7 cells stably
expressing Smac-GFP were generated. We then treated these
cells with ActD plus Q-VD-OPh or TNF without caspase inhibi-
tors and examined them by live-cell imaging (Figure 2A).
Smac-GFP was released from the majority of mitochondria, yet
punctate Smac-GFP distribution persisted in some cells.
Following UV plus Q-VD-OPh treatment the punctate distribution
of Smac following MOMP colocalized with matrix mCherry,
demonstrating that the observed puncta corresponded to mito-
chondria (Figure 2B; Movie S2). We also examined the
permeabilization of mitochondria in MCF-7 cells coexpressing
Smac-GFP and Omi-mCherry following treatment with ActD in
the presence of Q-VD-OPh and assessed by live-cell imaging
(Figure 2C). Incomplete release of Omi-mCherry was observed
in the same intact mitochondria that failed to release Smac-GFP,
similar to our results in HeLa cells. Finally, we also treated wild-
type murine embryonic fibroblasts (WT MEFs) stably expressing
Omi-mCherry and examined them by live-cell microscopy.
Similar to other cell types tested, iMOMP was detected in WT
MEFs as evidenced by continued mitochondrial retention of
Omi-mCherry following MOMP (Figure S2).
Studies have suggested that caspase activity is required
to ensure complete MOMP during apoptosis (Lakhani et al.,lopmental Cell 18, 802–813, May 18, 2010 ª2010 Elsevier Inc. 803
Figure 1. Incomplete Mitochondrial Outer Membrane Permeabilization during Apoptosis
(A) HeLa cells expressing Omi-mCherry, Smac-GFP, or cytochrome c-GFP were treated with STS (1 mM) plus Q-VD-OPh (20 mM) and imaged every 5 min.
Regions were drawn around cells, and punctate/diffuse and brightness indices were plotted and displayed relative to the onset of MOMP (time point 0). Data
were scaled and represent the average of 15 cells. Error bars represent standard error of the mean.
(B) HeLa cells expressing Smac-GFP were treated with STS (1 mM) or ActD (1 mM) plus Q-VD-OPh (20 mM) and imaged every 10 min by live-cell confocal micros-
copy. Representative confocal micrographs covering the onset and duration of MOMP are shown. The time of each frame relative to the start of image acquisition
is shown. Arrows denote cells undergoing iMOMP.
(C) HeLa cells expressing Smac-GFP were treated for 16 hr with STS (1 mM), ActD (1 mM), or UV (18 mJ/cm2) plus Q-VD-OPh (20 mM) and quantified for the occur-
rence of iMOMP. The percentage cells displaying iMOMP as a percentage of cells that had undergone MOMP (minimum 100 cells counted) is shown and error
bars represent the standard deviation (SD) from three independent experiments.
(D) HeLa cells expressing Smac-GFP and mito-dsRed were treated with UV (18mJ/cm2) plus Q-VD-OPh (20 mM) and imaged every 10 min by live-cell confocal
microscopy. Representative confocal micrographs covering the onset and duration of MOMP are shown. Arrows denote cells undergoing iMOMP. Line scans
indicate colocalization of Smac-GFP and mito-dsRed and correlate to the line drawn in the images (E) HeLa cells expressing Smac-GFP and Omi-mCherry were
treated with ActD (1 mM) plus Q-VD-OPh (20 mM) and imaged every 10 min by live-cell confocal microscopy. Representative confocal micrographs pre- and post-
MOMP are shown. Arrows denote cells undergoing iMOMP. Line scans indicate colocalization of Smac-GFP and Omi-mCherry and correlate to the lines drawn in
the images (F) HeLa cells expressing Smac-GFP were treated for 16 hr with UV (18 mJ/cm2) plus Q-VD-OPh (20 mM), fixed and immunostained with anti-cyto-
chrome c antibody. Representative confocal micrographs pre- and post-MOMP are shown. Line scans indicate colocalization of Smac-GFP and cytochrome c
and correlate to the line drawn in the images. Scale bars represent 10 mm. See also Figure S1.
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of caspase activity by carrying out live-cell imaging of TNF-
treated HeLa cells expressing Smac-GFP in the absence of cas-
pase inhibitors (Figure 2D; Movie S3). Propidium iodide uptake
was used to assess plasma membrane permeabilization. Incom-
plete MOMP was observed in the absence of caspase inhibitors,
as evidenced by the presence of intact mitochondria in cells that804 Developmental Cell 18, 802–813, May 18, 2010 ª2010 Elsevier Inhad undergone caspase-dependent plasma membrane perme-
abilization. These data demonstrate that iMOMP occurs inde-
pendently of caspase activity and in different cell types.
Characterization of iMOMP
We next addressed whether any intact mitochondria that re-
mained following MOMP were functional by examining whetherc.
Figure 2. Incomplete MOMP Is Cell-Type and Caspase Independent
(A) MCF-7 cells expressing Smac-GFP were treated with UV (18 mJ/cm2) plus Q-VD-OPh (20 mM) or TNF (10 ng/ml) and imaged every 10 min by live-cell confocal
microscopy. Representative confocal micrographs pre- and post-MOMP are shown.
(B) MCF-7 cells expressing Smac-GFP and matrix-targeted mCherry were treated with ActD (1 mM) plus Q-VD-OPh (20 mM) and imaged every 10 min by live-cell
confocal microscopy. Representative confocal micrographs pre- and post-MOMP are shown. Line scans indicate colocalization of Smac-GFP and mito-dsRed
and correlate to the line drawn in the images.
(C) MCF-7 cells expressing Smac-GFP and Omi-mCherry were treated with ActD (1 mM) plus Q-VD-OPh (20 mM) and imaged every 10 min by live-cell confocal
microscopy. Representative confocal micrographs pre- and post-MOMP are shown and arrows denote cells undergoing iMOMP.
(D) HeLa cells expressing Smac-GFP were treated with TNF (10 ng/ml) in the presence of propidium iodide (1 mg/ml) and imaged every 10 min by live-cell confocal
microscopy. Representative confocal micrographs pre- and post-MOMP are shown. Scale bars represent 10 mm. See also Figure S2.
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Smac-GFP were treated with STS in the presence of Q-VD-
OPh for 1 or 4 days, incubated with the potentiometric dye
TMRE, and imaged (Figure 3A). In line with published data
(Waterhouse et al., 2001), at 1 day post-MOMP many mitochon-
dria maintained DJm, as determined by TMRE positivity. At later
time points (4 days), intact mitochondria maintained DJm, as
shown by colocalization of Smac-GFP and TMRE.
Protection from CICD following MOMP typically occurs over
several days, involving removal of mitochondria by mitophagy
and requires mitochondrial repopulation (Colell et al., 2007).
Therefore, we imaged cells over extended time periods to inves-
tigate the fate of intact mitochondria. MCF-7 cells expressing
Smac-GFP were treated with UV in the presence of Q-VD-OPh
and followed over a period of 3 days. In cells displaying iMOMP,Deveintact mitochondria that had failed to undergo MOMP typically
persisted in cells over 3 days, indicating that failure of mitochon-
dria to undergo MOMP is long-lived (Figure S3). Intriguingly, in
some cells mitochondrial repopulation occurred following
MOMP, which was visualized by a gradual increase in Smac-
GFP puncta over time (Figure 3B; Movie S4). Closer examination
revealed several examples of apparent division of intact mito-
chondria, occurring even at early time points post-MOMP
(Figure 3C).
Following from these findings, we addressed the effect of
mitochondrial dynamics on iMOMP. Mitochondrial fission was
induced through transient addition of p-trifluoromethoxy
carbonyl cyanide phenyl hydrazone (FCCP), which is known
to induce mitochondrial fission by a Drp-1-dependent
mechanism (Cereghetti et al., 2008). Conversely, inhibition oflopmental Cell 18, 802–813, May 18, 2010 ª2010 Elsevier Inc. 805
Figure 3. Characterization of iMOMP
(A) HeLa cells expressing Smac-GFP were treated with STS (1 mM) and Q-VD-OPh (20 mM). At various times posttreatment cells were incubated with TMRE
(50 nM) and imaged by confocal microscopy. Representative images are shown and arrows denote intact mitochondria.
(B) MCF-7 cells expressing Smac-GFP were treated with UV (18 mJ/cm2) plus Q-VD-OPh (20 mM) and imaged every 20 min by live-cell confocal microscopy.
Numbered arrows denote the same cell at different time points. Blue arrow denotes cell that undergoes MOMP at a late time point. The time of each frame relative
to the start of image acquisition is shown.
(C) Magnified panels from experiment described in (B). The time of each frame relative to the start of image acquisition is shown.
(D) Left: HeLa cells were transfected with control or Drp-1 targeting shRNA vectors. Four days posttransfection and selection, cells were probed for Drp-1 levels
by western blot; ns denotes nonspecific protein used as loading control. Right: HeLa or HeLa Drp-1 knockdown cells expressing mito-dsRed were analyzed by
confocal microscopy, and representative micrographs are shown.
(E) HeLa cells expressing mito-dsRed and Smac-GFP treated with DMSO or FCCP (50 mM) and Drp-1 knockdown or control cells expressing mito-dsRed and
Smac-GFP were treated with STS (1 mM) and Q-VD-OPh (20 mM). Following overnight treatment, cells were assessed. Scale bars represent 10 mm. See also
Figure S3.
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regulation of Drp-1. Efficient knockdown of Drp-1, as detected
by immunoblot, resulted in cells with hyperfused mitochondrial
networks (Figure 3D). HeLa expressing Smac-GFP and mito
dsRed were then treated with STS in the presence of Q-VD-
OPh and assessed for iMOMP the following day. Inhibition of
mitochondrial fission through Drp-1 knockdown effectively
reduced the incidence of iMOMP (Figure 3E). In contrast,
promotion of fission by FCCP treatment increased the number
of cells displaying iMOMP (Figure 3E). Taken together, these
results demonstrate a role for mitochondrial dynamics in the
phenomenon of iMOMP.806 Developmental Cell 18, 802–813, May 18, 2010 ª2010 Elsevier InIncomplete MOMP Correlates with Protection
from CICD
Incomplete MOMP represents a means of providing nonpermea-
bilized mitochondria that may facilitate cellular recovery
following MOMP. To determine whether there was a direct corre-
lation between iMOMP and recovery following MOMP, we em-
ployed a single-cell clonogenic survival assay. For this purpose
we employed HeLa cells with enforced expression of GAPDH,
as described elsewhere (Collell, et al., 2007), and expressing
Smac-GFP to visualize MOMP. Cells were cultured at one cell
per well, treated with STS in the presence of Q-VD-OPh, and
scored the following day as displaying complete or incompletec.
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outgrowth (Figure 4A). We observed that cells displaying iMOMP
were statistically more likely to display clonogenic recovery than
those displaying complete MOMP (p < 0.001), thereby demon-
strating a direct correlation between incomplete MOMP and
survival under conditions of MOMP.
To examine this further, we employed another approach.
Because Smac-GFP is degraded upon mitochondrial release,
we reasoned that under conditions of CICD, cells that had under-
gone complete MOMP and those that had undergone iMOMP
may be separated based on differential GFP fluorescence inten-
sity (Figure 4B). HeLa cells expressing GAPDH and Smac-GFP
were treated with different doses of STS in the presence of Q-
VD-OPh. Flow cytometry analysis demonstrated a decrease in
Smac-GFP fluorescence after STS plus Q-VD-OPh treatment
(Figure 4C). Accordingly, we sorted cells into relatively low and
high Smac-GFP fluorescent populations, and examined them
for iMOMP by fluorescence microscopy (Figure S4A). The
percentage of cells displaying iMOMP was enriched in the higher
Smac-GFP fluorescence population relative to the low fluores-
cence population (approximately 50% versus 10%) and was
independent of STS concentration (Figure 4D). Because this
provided us with a means of enriching for cells displaying iM-
OMP, we investigated if there was a correlation between iMOMP
and recovery from CICD. Following STS plus Q-VD-OPh treat-
ment and cell sorting, equal numbers of cells from high and
low Smac-GFP fluorescent populations were assessed for clo-
nogenic outgrowth (Figure 4E). As a control for efficient induction
of MOMP, HeLa cells expressing GAPDH and Smac-GFP were
also examined for clonogenic outgrowth following STS treatment
in the absence of caspase inhibitors, and no survival was
observed (Figure 4E). Importantly, iMOMP correlated with
cellular protection from conditions of CICD, because there was
a marked increase in clonogenic recovery of cells from the
high Smac-GFP fluorescent population relative to cells from
the low fluorescence population following STS plus Q-VD-OPh
treatment (Figure 4E). This protection was not observed in the
absence of caspase inhibition, and was therefore not due to
increased numbers of cells that had failed to engage the
apoptotic pathway.
Although the percentage of cells displaying iMOMP was inde-
pendent of the dose of STS, higher doses of the agent resulted in
poorer clonogenic growth. We suspected that this could be due
to cell damage by the STS treatment, independent of MOMP. To
address this, we used HeLa cells expressing Bcl-xL and exam-
ined MOMP (by cytochrome c immunostaining) and clonogenic
survival following treatment with STS. Of note, whereas Bcl-xL
inhibited MOMP at all doses of STS, clonogenic growth was
observed only at the lower doses (Figure S4B). Therefore, the
decreased clonogenic survival we observed at increased doses
of STS in the experiment in Figure 4E is likely representative of
cell damage irrespective of apoptosis.
Bax and Bak Fail to Be Activated on Nonpermeabilized
Mitochondria
We next investigated the underlying mechanism(s) that resulted
in certain mitochondria being refractory to MOMP. Pro- and anti-
apoptotic members of the Bcl-2 family regulate the integrity of
the mitochondrial outer membrane; during apoptosis activationDeveof the proapoptotic proteins Bax and/or Bak induces MOMP
(Chipuk and Green, 2008). We monitored Bax translocation
because the proapoptotic activity of Bax is inextricably linked
to its translocation from the cytoplasm to mitochondria. HeLa
cells expressing GFP-Bax and Omi-mCherry were treated with
UV or ActD in the presence of Q-VD-OPh and examined by
live-cell microscopy. Mitochondrial release of Omi-mCherry
was accompanied by mitochondrial translocation of GFP-Bax
(Figure 5A; Movie S5). Examination of cells displaying iMOMP re-
vealed that intact mitochondria failed to accumulate GFP-Bax,
suggesting that the failure of certain mitochondria to undergo
MOMP is associated with an absence of Bax activation at these
mitochondria.
To rule out any confounding effects of endogenous Bax or
Bak, we carried out similar imaging experiments in Bax/Bak
double knockout MEF (DKO MEF) expressing GFP-Bax and
Omi-mCherry. Expression of GFP-Bax in DKO MEF fully restored
their apoptotic sensitivity (data not shown). DKO MEF express-
ing GFP-Bax and Omi-mCherry were treated with either UV or
ActD in the presence of Q-VD-OPh and imaged the following
day. As we previously observed, GFP-Bax failed to translocate
to intact mitochondria in cells displaying iMOMP (Figure 5B).
A previous study has shown that Bax and Bak form clusters
adjacent to mitochondria following their activation (Nechushtan
et al., 2001). However, following MOMP we could clearly detect
the presence of intact mitochondria that had no GFP-Bax in
close proximity, indicating a failure of Bax activation on these
mitochondria.
We employed a similar approach to address the role of Bak
during incomplete MOMP by expressing GFP-Bak and Omi-
mCherry in DKO MEF. Expression of GFP-Bak in these cells fully
restored their apoptotic sensitivity (data not shown). DKO cells
expressing GFP-Bak and Omi-mCherry were treated with either
UV or ActD in the presence of Q-VD-OPh and imaged the
following day (Figure 5C). As expected, GFP-Bak displayed
constitutive mitochondrial localization. In cells that displayed iM-
OMP, GFP-Bak was nevertheless present on mitochondria that
remained intact, suggesting that Bak, similar to Bax, fails to be
activated on these mitochondria.
Antiapoptotic Bcl-2 Proteins Promote iMOMP
The failure to activate Bax/Bak proteins on some mitochondria
might allow them to evade MOMP. We hypothesized that this
failure to activate Bax and Bak may be due to antiapoptotic
Bcl-2 activity. To address this, we investigated Bcl-2 levels on
intact mitochondria following MOMP. HeLa cells expressing
Omi-mCherry and GFP-Bcl-2 were treated with UV or ActD in
the presence of Q-VD-OPh and imaged the following day
(Figure 6A; Figure S5). In cells displaying iMOMP, increased
levels of GFP-Bcl-2 were observed on intact versus permeabi-
lized mitochondria, suggesting that antiapoptotic Bcl-2 proteins
are responsible for protecting the intact mitochondria.
To further test this hypothesis, we employed cell fusion exper-
iments between HeLa cells expressing Smac 1-60 mCherry and
Cerulean and HeLa cells overexpressing Bcl-2 and Smac-YFP.
Fused cells were identified by the presence of cytosolic Cerulean
protein in Smac-YFP cells. Cells were treated with UV in the
presence of Q-VD-OPh and imaged (Figure 6B). In fused cells,
mitochondria expressing Smac YFP and Bcl-2 failed to undergolopmental Cell 18, 802–813, May 18, 2010 ª2010 Elsevier Inc. 807
Figure 4. Incomplete MOMP Correlates with Cellular Recovery from CICD
(A) Left/center: Representative confocal micrographs from single-cell cultures showing complete (left) and incomplete (center) MOMP in HeLa cells expressing
GAPDH and Smac-GFP following 16 hr treatment with STS (1 mM) plus Q-VD-OPh (20 mM). Right: Widefield micrograph of a proliferating colony 14 days later.
Inset numbers refer to the number of proliferating colonies that arose/the number of cells analyzed that display either complete or incomplete MOMP. The differ-
ence between groups was assessed by chi-square analysis (p < 0.001).
(B) Schematic experimental outline. HeLa cells expressing Smac-GFP following STS treatment leading to complete MOMP will display less relative fluorescence
than those displaying iMOMP. These cell populations are sorted by flow cytometry and assessed for their ability to exhibit clonogenic survival.
(C) HeLa cells expressing Smac-GFP were treated for 16 hr with STS (0.5-4 mM) plus Q-VD-OPh (20 mM) and analyzed by flow cytometry for GFP fluorescence
intensity (inset, mean fluorescence intensity [MFI]). Gates denote populations covering 20% lowest and highest Smac-GFP fluorescent populations that were
sorted. Quantification of Smac-GFP MFI of STS plus Q-VD-OPh-treated cells from three independent experiments expressed as percentage relative to control
untreated cells. Error bars represent SD.
(D) HeLa cells expressing Smac-GFP were treated for 16 hr with STS (0.5-4 mM) plus Q-VD-OPh (20 mM) and sorted into the 20% highest and lowest GFP-ex-
pressing cells and analyzed by microscopy for iMOMP. Number of cells displaying iMOMP as a percentage of cells displaying MOMP is shown, a minimum 100
cells per condition were counted. Results are from three independent experiments ± SD.
(E) HeLa cells expressing GAPDH and Smac-GFP were treated for 16 hr with STS (0.5 mM-4 mM) plus Q-VD-OPh (20 mM) and sorted into 20% highest and lowest
GFP-expressing populations. Then 2 3 105 cells from each population were plated down in the presence of Q-VD-OPh (20 mM) and examined for clonogenic
outgrowth. As a control, 1 3 106 cells were treated with STS (0.5-4 mM) for 16 hr and examined for clonogenic outgrowth (middle panel). Colony number from
three independent experiments; error bars represent SD. Scale bars represent 10 mm. See also Figure S4.
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control mitochondria. This result indicates that increased levels
of antiapoptotic Bcl-2 proteins on certain mitochondria can
protect these mitochondria from MOMP.
We then examined the effects of ABT-737, a compound that
has been developed as a BH3 mimetic that inhibits the antiapop-
totic function of Bcl-2, Bcl-xL, and Bcl-w (Oltersdorf et al., 2005).
We treated HeLa cells expressing Smac-GFP with ActD in the
presence of Q-VD-OPh. Exposure of cells to ABT-737 in the
absence of ActD did not induce MOMP or affect cell viability
(Figure 6E and data not shown). The following day, after cells
had undergone MOMP, ABT-737 or its inactive enantiomer808 Developmental Cell 18, 802–813, May 18, 2010 ª2010 Elsevier Inwas added and cells displaying iMOMP were imaged by live-
cell microscopy (Figure 6C; Movies S6 and S7). Strikingly,
following treatment with ABT-737, intact mitochondria in these
cells underwent complete MOMP, whereas intact mitochondria
persisted in cells treated with enantiomer. Alternatively, cells
were treated overnight with STS plus Q-VD-OPh or UV plus
Q-VD-OPh in the presence of ABT-737 or enantiomer and
assessed for iMOMP the following day. Coincubation with
ABT-737 significantly reduced the number of cells displaying
iMOMP either before or after UV or STS treatment relative to
those that were treated with enantiomer (Figure 6D). These
data show that, following different apoptotic stimuli, iMOMPc.
Figure 5. Bax and Bak Fail to Be Activated on Nonpermeabilized Mitochondria
(A) HeLa cells expressing GFP-Bax and Omi-mCherry were treated with UV (18 mJ/cm2) plus Q-VD-OPh (20 mM) and imaged every 10 min by live-cell microscopy.
Representative confocal micrographs covering the onset and duration of MOMP are shown. The time of each frame relative to the start of image acquisition is
shown.
(B) Bax/Bak DKO MEFs expressing GFP-Bax and Omi-mCherry were untreated or treated with UV (18 mJ/cm2) or ActD (1 mM) plus Q-VD-OPh (20 mM). Repre-
sentative confocal micrographs are shown. Arrows denote intact mitochondria that fail to have GFP-Bax in close proximity.
(C) Bax/Bak DKO MEFs expressing GFP-Bak and Omi-mCherry were untreated or treated with UV (18mJ/cm2) or ActD (1 mM) plus Q-VD-OPh (20 mM). Repre-
sentative confocal micrographs are shown. Arrows denote intact mitochondria. Line scans indicate colocalization of Omi-mCherry and GFP-Bak and correlate to
the line drawn in the images. Scale bars represent 10 mm.
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totic Bcl-2 function, supporting a model that antiapoptotic Bcl-2
protein function enables iMOMP.
Given the effect of ABT-737 on incidence of iMOMP, we next
examined the effect of ABT-737 treatment on the ability of cells
to recover from conditions of CICD. HeLa cells expressing
GAPDH were treated with STS in the presence or absence of
Q-VD-OPh. Cells were treated with ABT-737 or enantiomer
either prior to or after treatment with STS and assessed for clo-
nogenic survival. Incubation of cells with ABT-737 alone had no
effect on cell viability (Figure 6E). Caspase inhibition promoted
clonogenic recovery, indicating protection from CICD. However,
incubation of cells with ABT-737 either prior to or after STS plus
Q-VD-OPh treatment effectively blocked clonogenic survival,
further supporting a key role for intact mitochondria in the ability
of cells to be protected from conditions of CICD and recover
following MOMP.DeveDISCUSSION
Mitochondrial outer membrane permeabilization initiates
apoptosis by activating executioner caspases; however, even
when caspase activation is blocked, cells nonetheless die
following MOMP, an observation believed to be explained by
the requirement for intact mitochondria to sustain cellular metab-
olism. This view is supported by data from our own lab (Collell
et al., 2007) showing that enforced expression of the metabolic
enzyme GAPDH can permit recovery following MOMP. However,
previous studies failed to address how cells recover and repopu-
late their mitochondria following MOMP. Our results show that
during apoptosis, MOMP can be incomplete, leaving some mito-
chondria intact. These data demonstrate a correlation between
iMOMP and clonogenic survival following MOMP, and show
that this survival can be blocked if iMOMP is disrupted. Based
on these results, we propose that iMOMP provides a criticallopmental Cell 18, 802–813, May 18, 2010 ª2010 Elsevier Inc. 809
Figure 6. Antiapoptotic Bcl-2 Proteins Promote iMOMP
(A) HeLa cells expressing GFP-Bcl-2 and Omi-mCherry were untreated or treated with UV (18 mJ/cm2) plus Q-VD-OPh (20 mM). Representative confocal micro-
graphs are shown. Line scans indicate co-localization of Omi-mCherry and GFP-Bcl-2 and correlate to the line drawn in the images.
(B) HeLa cells expressing Smac 1-60-mCherry/Cerulean and HeLa cells expressing Bcl-2 and Smac-YFP were fused, treated overnight with UV (18mJ/cm2) plus
Q-VD-OPh (20 mM) and imaged by live-cell microscopy. Representative confocal micrographs pre- and post-MOMP are shown. Arrow denotes intact mitochon-
dria.
(C) MCF-7 cells expressing Smac-GFP were treated overnight with ActD (1 mM) plus Q-VD-OPh (20 mM) then treated the following day with enantiomer or ABT-
737 (both 10 mM) and imaged every 10 min by live-cell confocal microscopy. The time of each frame relative to the start of image acquisition is shown and arrows
denote cells undergoing iMOMP.
(D) HeLa cells expressing Smac-GFP were treated for 16 hr with ABT-737 or enantiomer (both 1 mM) then treated for 16 hr with STS (1 mM) plus Q-VD-OPh (20 mM)
or (18mJ/cm2) plus Q-VD-OPh. The percentage of cells displaying iMOMP as a percentage of cells displaying MOMP is shown from three independent exper-
iments (minimum 100 cells counted). Error bars represent SD.
(E) HeLa cells expressing GAPDH and Smac-GFP were treated with STS (0.5 or 1 mM) ± Q-VD-OPh (20 mM) for 16 hr. Where indicated, prior to or after STS treat-
ment, ABT-737 or enantiomer was added (1 mM) for 16 hr. As indicated, Q-VD-OPh was replenished for a further 3 days and cells were assessed for clonogenic
outgrowth. As a control, HeLa cells expressing GAPDH and Smac-GFP were cultured ± ABT-737 (1 mM) for 3 days. Colony number from three independent exper-
iments ± SD is shown. Scale bars represent 10 mm. See also Figure S5.
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from MOMP (Figure 7).
Our discovery that MOMP can be incomplete contrasts with
one of our previous studies that concluded MOMP is an all-or-
nothing event based on imaging cell cells expressing cyto-
chrome c-GFP (Goldstein et al., 2000). By making use of Smac
and Omi fluorescent fusion proteins, we suspect that our ability
to visualize iMOMP has been greatly enhanced for two reasons.810 Developmental Cell 18, 802–813, May 18, 2010 ª2010 Elsevier InUnlike cytochrome c, Smac and Omi fluorescent fusion proteins
undergo cytoplasmic degradation following MOMP, thereby
facilitating the detection of intact mitochondria that remain
brighter (Figure 1A). Second, unlike cytochrome c, Smac and
Omi fluorescent fusion proteins displayed minimal mislocaliza-
tion in healthy cells, further enhancing the resolution with which
MOMP could be tracked. However we also found, using imaging
techniques that are improved from those earlier (Goldstein et al.,c.
Figure 7. Model of Mitochondrial Repopulation
Required for Cellular Recovery from MOMP
Following an apoptotic stimulus, the majority of mitochon-
dria within a cell undergo MOMP. However, MOMP can be
incomplete; some mitochondria remain intact due to
increased levels of antiapoptotic Bcl-2 proteins on their
outer membranes. Over time, these intact mitochondria
repopulate the cell, enabling cell survival and proliferation
under conditions where caspase function is inhibited.
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of cytochrome c-GFP can also be observed to be incomplete
(Figure S1). That these mitochondria are indeed intact is evi-
denced by the presence of all IMS proteins tested, and by the
persistence of DJm (Figure 3A).
How do mitochondria selectively evade MOMP? Our data
support a model whereby some mitochondria within a cell
have increased antiapoptotic Bcl-2 activity and are therefore
refractory to MOMP. This is based on several findings: Bax failed
to accumulate on mitochondria and Bak does not cluster adja-
cent to mitochondria that have not undergone MOMP (Figure 5),
increased levels of Bcl-2 can protect specific mitochondria from
MOMP (Figures 6A and 6B), and the Bcl-2 antagonist ABT-737
induces the permeabilization of intact mitochondria in cells dis-
playing iMOMP (Figures 6C and 6D). Interestingly, the selective
failure of Bax to accumulate at nonpermeabilized mitochondria
suggests that the critical steps of Bax activation (e.g., conforma-
tional changes leading to oligomerization) likely occur at the
target mitochondrial membrane rather than in the cytoplasm as
supported by a recent study showing that Bax activation
requires a membrane environment (Lovell et al., 2008). Although
ABT-737 effectively promoted complete MOMP in most cells,
some cells were refractory to its addition (not shown). This may
be attributable to the inability of ABT-737 to inhibit all antiapop-
totic Bcl-2 family proteins such as Mcl-1 (Oltersdorf et al., 2005)
or, perhaps more interestingly, there may be alternative mecha-
nisms that allow mitochondria to selectively evade MOMP.
Mitochondrial fragmentation accompanies but is not required
for MOMP (Estaquier and Arnoult, 2007; Parone et al., 2006). Our
results demonstrate that mitochondrial dynamics play a key role
in iMOMP: inhibition of mitochondrial fission reduced the inci-
dence of iMOMP whereas promoting fission had the opposite
effect (Figure 3E). Presumably this outcome relates to the inter-
connectivity between the IMS of different mitochondria; a mito-
chondrion that is resistant to MOMP when in isolation wouldDevelopmental Cell 18be expected to release its IMS contents if it
were fused to a permeabilized mitochondria.
Because MOMP and mitochondrial fragmenta-
tion occur almost simultaneously, it is currently
unclear if intact mitochondria are separated
prior to MOMP or undergo fission at the time
of MOMP.
The correlation between iMOMP and clono-
genic survival under conditions of CICD coupled
with the ability to block protection by inhibiting
iMOMP supports a functional consequence of
iMOMP (Figures 4A, 4E, and 6E). Recoveryfrom MOMP typically takes several days (Colell et al., 2007).
Long-term imaging revealed that intact mitochondria persist
over time and that mitochondrial repopulation occurs in some
cells. Intact mitochondria could be observed to apparently
undergo fission, even at early periods post-MOMP. We propose
that iMOMP provides a source of ‘‘seed’’ mitochondria that are
required to regenerate the mitochondrial population prior to full
cell recovery. Unfortunately, it remains technically challenging
to permanently mark these mitochondria and follow them over
time. Therefore, another possibility is that functional, nonper-
meabilized mitochondria are required only temporarily to
compensate for the functional decline that is observed in per-
meabilized mitochondria over time (Colell et al., 2007). However,
this model would require an alternative means of generating
healthy mitochondria by resealing of the mitochondrial outer
membrane following MOMP. We have not observed such an
appearance of intact mitochondria in cells displaying complete
MOMP, but such a mechanism cannot be formally excluded.
Previously, we have shown that recovery post-MOMP involves
autophagic removalof mitochondria, also termedmitophagy,prior
to cell recovery (Colell et al., 2007). In the present study we found
that intact mitochondria persist in cells at least over a 3 day period,
suggesting that they are spared from removal (Figure S3). In the
context of mitophagy, cells displaying iMOMP may serve as
a useful means to study the mechanisms by which a cell can
discriminate between damaged and healthy mitochondria.
Perhaps of direct clinical relevance, we show that ABT-737
can effectively inhibit iMOMP and block cellular protection
from CICD (Figure 6). This result suggests that the chemothera-
peutic potency of ABT-737 may also be linked to its ability to
block tumor cell resistance to conditions of CICD by inhibiting
iMOMP. Alternatively, in scenarios where caspase inhibitors
might be used as cytoprotective agents then one might predict
that promotion of iMOMP would facilitate cell survival leading
to greater therapeutic efficacy., 802–813, May 18, 2010 ª2010 Elsevier Inc. 811
Developmental Cell
Incomplete MOMP and Cell SurvivalEXPERIMENTAL PROCEDURES
Cell Treatments
To induce apoptosis, cells were treated with the indicated concentrations of
staurosporine (Sigma), human TNF (Peprotech), actinomycin D (Sigma), or
UV irradiated using a Stratagene UV crosslinker. Where indicated, the pan-
caspase inhibitor Q-VD-OPh was added to a final concentration of 20 mM
(EMD Biosciences). ABT-737 and enantiomer were obtained from Abbot Labo-
ratories. Where indicated, cells were incubated with 25 mM FCCP (Sigma) for
1 hr prior to washing and readdition of culture medium.
Microscopy
Cells were plated on dishes containing fibronectin-coated coverslips (Mattek)
24 hr prior to treatment and imaged using a spinning disk confocal microscope
(Zeiss). For time-lapse experiments, media on the cells was supplemented
with HEPES (20 mM) and 2-mercaptoethanol (55 mM) prior to imaging.
Clonogenic Survival Assays
Following overnight treatment, HeLa cells expressing Smac GFP and GAPDH
were sorted into the lowest and highest 20% fluorescent populations, and
23 105 cells from both populations were washed and plated in a 12-well plate.
For the ABT-737 clonogenic assays, 2.53 103 cells/per well were plated down
on a 12-well plate 2 days prior to treatment. The following day, cells were
treated with ABT-737 or enantiomer overnight (both at 1 mM), then treated
with ABT-737 or enantiomer plus STS ± Q-VD-OPh for 8 hr. Where noted,
ABT-737 or enantiomer was added at 1 mM for 16 hr posttreatment. The
following, day cells were washed and incubated with new media ± Q-VD-
OPh. Where added, Q-VD-OPh was refreshed for the next 2 days. Following
clonogenic outgrowth, colonies were visualized by staining with methylene
blue 0.1% w/v in methanol/water 50% v/v for 20 min.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, Supplemental Experimental
Procedures, and seven movies and can be found with this article online at
doi:10.1016/j.devcel.2010.03.014.
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